Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATING CHANGES: Barclays, Nomura Cut Unilever Price Target

Tue, 01st Oct 2013 09:52

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning and Monday afternoon:
----------
FTSE 100
----------
PANMURE GORDON REPLACES SHIRE WITH HIKMA AS 'TOP PICK'
----------
MORGAN STANLEY RAISES BT GROUP PRICE TARGET TO 350 (310) PENCE - 'EQUAL-WEIGHT'
----------
Jefferies reiterates Buy rating for Kingfisher and increases its target price to 440p, from 400p
----------
HSBC RAISES VODAFONE PRICE TARGET TO 255 (230) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES VODAFONE PRICE TARGET TO 255 (230) PENCE - 'OVERWEIGHT'
----------
NOMURA CUTS UNILEVER NV PRICE TARGET TO 32.25 (34.30) EUR - 'BUY'
----------
BARCLAYS CUTS UNILEVER NV PRICE TARGET TO 35 (36) EUR - 'OVERWEIGHT'
----------
TRADERS: SOCGEN CUTS BRITISH LAND TO 'HOLD' ('BUY')
----------
S&P CAPITAL IQ CUTS RIO TINTO TO 'SELL' ('BUY') - PRICE TARGET 2,700 (3,800) PENCE
----------
FTSE 250
----------
PANMURE CUTS LADBROKES PRICE TARGET TO 171 (188) PENCE - 'HOLD'
----------
PANMURE RAISES AVEVA GROUP PRICE TARGET TO 2374 (2174) PENCE - 'HOLD'
----------
HSBC RAISES STAGECOACH TO 'NEUTRAL' ('UNDERWEIGHT') - TARGET 325 (305) PENCE
----------
HSBC RAISES NATIONAL EXPRESS PRICE TARGET TO 290 (280) PENCE - 'OVERWEIGHT'
----------
Goldman Sachs CUTS HIKMA PHARMACEUTICALS PRICE TARGET TO 1180 (1190) PENCE - 'NEUTRAL'
----------
HSBC RAISES FIRSTGROUP PRICE TARGET TO 115 (110) PENCE - 'NEUTRAL'
----------
HSBC RAISES GO-AHEAD GROUP PRICE TARGET TO 1810 (1635) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK RAISES HAYS PRICE TARGET TO 105 (90) PENCE - 'HOLD'
----------
TRADERS: SOCGEN CUTS SEGRO TO 'HOLD' ('BUY')
----------
TRADERS: SOCGEN CUTS DERWENT TO 'HOLD' ('BUY')
----------
NOMURA CUTS LADBROKES PRICE TARGET TO 145 (165) PENCE - 'REDUCE'
----------
ALL-SHARE AND AIM
----------
WH Ireland raises Findel target price to 310p from 250p, reiterating a Buy rating
----------
CS CUTS AFRICAN MINERALS TO 'NEUTRAL' ('OUTPERFORM') - TARGET 280 (350) PENCE
----------
PANMURE RAISES INNOVATION GROUP PRICE TARGET TO 41 (38) PENCE - 'BUY'
----------
CANACCORD RAISES HELLERMANNTYTON PRICE TARGET TO 295 (280) PENCE - 'BUY'
----------
CANACCORD CUTS IOMART GROUP TO 'HOLD' ('BUY') - TARGET 300 PENCE
----------
NUMIS RAISES RENEW HOLDINGS PRICE TARGET TO 185 (148) PENCE - 'BUY'
----------
JPM RAISES NEW WORLD RESOURCES PRICE TARGET TO 59 (50) PENCE - 'UNDERWEIGHT'
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
12 Aug 2021 16:04

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
6 Aug 2021 17:06

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

Read more
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.